Assessment of Abuse Potential of Cebranopadol in Humans

NCT05256108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Abuse Potential

Interventions

DRUG: Oxycodone 40 mg
DRUG: Tramadol 600 mg
DRUG: Placebo
DRUG: Cebranopadol 600 µg
DRUG: Cebranopadol 1000 µg

Sponsor

Tris Pharma, Inc.